BRAF mutations: What are the treatment options?

Date 09 October 2016
Event ESMO 2016 Congress
Session New molecular challenges in CRC
Topics Anti-Cancer Agents & Biologic Therapy
Gastrointestinal Cancers
Presenter Fotios Loupakis
Authors F. Loupakis
  • Department Of Clinical And Experimental Oncology, Istituto Oncologico Veneto IOV IRCCS, 57100 - Livorno/IT